Literature DB >> 1607547

Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions.

D Proud1, G S Bailey, R M Naclerio, C J Reynolds, A A Cruz, P A Eggleston, L M Lichtenstein, A G Togias.   

Abstract

We have used assays for histamine and for the specific mast cell enzyme, tryptase, to examine the response of the nasal mucosa to provocation with several different stimuli and to evaluate the reliability of histamine as a marker of mast cell activation. High levels of histamine detected in baseline lavages of some subjects are not associated with any detectable tryptase, suggesting they are not mast cell derived. During pronounced immediate allergic responses, however, mast cell degranulation clearly occurs, and a striking correlation between histamine and tryptase is observed. This correlation is weaker when a more modest allergic response is induced, possibly reflecting differential diffusion of the two mediators across the epithelium. Provocation of susceptible individuals with cold, dry air leads to increased recoveries of both histamine and tryptase, confirming that mast cell degranulation occurs during this reaction. Although hyperosmolarity of the nasal mucosa may contribute to mast cell degranulation induced by cold, dry air, a brief exposure of the nasal cavity to hyperosmolar mannitol was not associated with measurable production of tryptase. The combined use of histamine and tryptase measurements can therefore provide useful evidence regarding the role of mast cell activation in the pathogenesis of inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1607547     DOI: 10.1016/0091-6749(92)90293-b

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  15 in total

Review 1.  Upper airways reactions to cold air.

Authors:  Alvaro A Cruz; Alkis Togias
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

2.  Synergistic effect of histamine and TNF-α on monocyte adhesion to vascular endothelial cells.

Authors:  Chong Chen; Damir B Khismatullin
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

3.  Mast cells drive mesenteric afferent signalling during acute intestinal ischaemia.

Authors:  Wen Jiang; Anthony J Kirkup; David Grundy
Journal:  J Physiol       Date:  2011-06-13       Impact factor: 5.182

4.  Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.

Authors:  L B Schwartz; T R Bradford; C Rouse; A M Irani; G Rasp; J K Van der Zwan; P W Van der Linden
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

5.  Histamine release upon adenosine 5'-monophosphate (AMP) nasal provocation in allergic subjects.

Authors:  R Polosa; C Pagano; G Prosperini; J L Low; D Dokic; M K Church; N Crimi
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

6.  Exposure assessment in Beijing, China: biological agents, ultrafine particles, and lead.

Authors:  Shuofei Dong; Maosheng Yao
Journal:  Environ Monit Assess       Date:  2009-11-11       Impact factor: 2.513

7.  Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.

Authors:  John A Eckman; Patricia M Sterba; Denise Kelly; Val Alexander; Mark C Liu; Bruce S Bochner; Donald W Macglashan; Sarbjit S Saini
Journal:  J Allergy Clin Immunol       Date:  2009-12-04       Impact factor: 10.793

8.  Modulation of tryptase secretion from human colon mast cells by histamine.

Authors:  Shao-Heng He; Hua Xie
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

Review 9.  The kinin system in rhinitis and asthma.

Authors:  D Proud
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 10.  Nonallergic rhinitis. Pathophysiology and models for study.

Authors:  G Philip; A G Togias
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.